Harmony Biosciences Holdings I (HRMY) — Free Cash Flow Yield

Biotech & Pharma

MetricValue
FCF Yield16.9%
Biotech & Pharma Sector Avg FCF Yield14.3%
Annual Free Cash Flow$355M
Market Cap$2.1B
P/E Ratio11.7x

Harmony Biosciences Holdings I's FCF yield of 16.9% is above the Biotech & Pharma sector average (14.3%).

Deep Dive Analysis Available

Harmony Biosciences (HRMY) FCF Analysis: Dated Runway

Read Full FCF Analysis →

Frequently Asked Questions

What is Harmony Biosciences Holdings I's (HRMY) free cash flow yield?

Harmony Biosciences Holdings I's (HRMY) free cash flow yield is 16.9%. That is above the Biotech & Pharma sector average (14.3%).

Is HRMY's free cash flow yield good?

At 16.9%, HRMY's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.

How much free cash flow does Harmony Biosciences Holdings I generate?

Harmony Biosciences Holdings I generated $355M in free cash flow, against a market cap of $2.1B.

How is free cash flow yield calculated?

Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.

Data from public filings. Not investment advice. Calculate your own FCF yield →